Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 28,647

Sort by:

Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Community Acquired Methicillin-Resistant Staphylococcus au...

April 2021 30 pages

Complement C1q Subcomponent - Drugs in Development, 2021

US$ 3,000.00

Complement C1q Subcomponent - Drugs in Development, 2021 SUMMARY Complement C1q Subcomponent - Drugs in Development, 2021 provides in depth analysis on Complement C1q Subcomponent targeted pipeline th...

April 2021 30 pages

Complement C1s Subcomponent (C1 Esterase or Complement Component 1 Subcomponent S or C1S or EC 3.4.21.42) - Drugs in Development, 2021

US$ 3,000.00

Complement C1s Subcomponent (C1 Esterase or Complement Component 1 Subcomponent S or C1S or EC 3.4.21.42) - Drugs in Development, 2021 SUMMARY Complement C1s Subcomponent (C1 Esterase or Complement Co...

April 2021 40 pages

Complement C3 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 1 or C3) - Drugs in Development, 2021

US$ 3,000.00

Complement C3 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 1 or C3) - Drugs in Development, 2021 SUMMARY Complement C3 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Prot...

April 2021 50 pages

Complement Factor B (Glycine Rich Beta Glycoprotein or C3/C5 Convertase or Properdin Factor B or PBF2 or CFB or EC 3.4.21.47) - Drugs in Development, 2021

US$ 3,000.00

Complement Factor B (Glycine Rich Beta Glycoprotein or C3/C5 Convertase or Properdin Factor B or PBF2 or CFB or EC 3.4.21.47) - Drugs in Development, 2021 SUMMARY Complement Factor B (Glycine Rich Bet...

April 2021 30 pages

Complement Factor D (C3 Convertase Activator or Adipsin or Properdin Factor D or CFD or EC 3.4.21.46) - Drugs in Development, 2021

US$ 3,000.00

Complement Factor D (C3 Convertase Activator or Adipsin or Properdin Factor D or CFD or EC 3.4.21.46) - Drugs in Development, 2021 SUMMARY Complement Factor D (C3 Convertase Activator or Adipsin or Pr...

April 2021 50 pages

Complement Factor H (Adrenomedullin Binding Protein or Beta 1 H Globulin or H Factor 1 or CFH or EC 4.2.1.2) - Drugs in Development, 2021

US$ 3,000.00

Complement Factor H (Adrenomedullin Binding Protein or Beta 1 H Globulin or H Factor 1 or CFH or EC 4.2.1.2) - Drugs in Development, 2021 SUMMARY Complement Factor H (Adrenomedullin Binding Protein or...

April 2021 35 pages

Complicated Intra-Abdominal Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Complicated Intra-Abdominal Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Complicated Intra-Abdominal Infections (Infectious Disease) - Drugs in Development, 2021 provides an ov...

April 2021 65 pages

Complicated Skin And Skin Structure Infections (cSSSI) (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Complicated Skin And Skin Structure Infections (cSSSI) (Infectious Disease) - Drugs in Development, 2021 SUMMARY Complicated Skin And Skin Structure Infections (cSSSI) (Infectious Disease) - Drugs in...

April 2021 30 pages

Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) (Hormonal Disorders) - Drugs in Development, 2021

US$ 2,000.00

Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) (Hormonal Disorders) - Drugs in Development, 2021 SUMMARY Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) (Hormonal Disorders) - Drugs i...

April 2021 30 pages

Congenital Ichthyosis (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Congenital Ichthyosis (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Congenital Ichthyosis (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Congenital Ichthyosis...

April 2021 30 pages

Conjunctivitis (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Conjunctivitis (Ophthalmology) - Drugs in Development, 2021 SUMMARY Conjunctivitis (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Conjunctivitis pipeline landscape. The repor...

April 2021 35 pages

Constipation (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Constipation (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Constipation (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Constipation pipeline landscape. The repor...

April 2021 55 pages

Copper Transporting ATPase 2 (Copper Pump 2 or Wilson Disease Associated Protein or ATP7B or EC 7.2.2.8) - Drugs in Development, 2021

US$ 3,000.00

Copper Transporting ATPase 2 (Copper Pump 2 or Wilson Disease Associated Protein or ATP7B or EC 7.2.2.8) - Drugs in Development, 2021 SUMMARY Copper Transporting ATPase 2 (Copper Pump 2 or Wilson Dise...

April 2021 30 pages

Corneal Graft Rejection (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Corneal Graft Rejection (Immunology) - Drugs in Development, 2021 SUMMARY Corneal Graft Rejection (Immunology) - Drugs in Development, 2021 provides an overview of the Corneal Graft Rejection pipeline...

April 2021 35 pages

Coronary Artery Disease (CAD) (Ischemic Heart Disease) (Cardiovascular) - Drugs in Development, 2021

US$ 2,000.00

Coronary Artery Disease (CAD) (Ischemic Heart Disease) (Cardiovascular) - Drugs in Development, 2021 SUMMARY Coronary Artery Disease (CAD) (Ischemic Heart Disease) (Cardiovascular) - Drugs in Developm...

April 2021 80 pages

Coronaviridae Infections (Respiratory) - Drugs in Development, 2021

US$ 2,000.00

Coronaviridae Infections (Respiratory) - Drugs in Development, 2021 SUMMARY Coronaviridae Infections (Respiratory) - Drugs in Development, 2021 provides an overview of the Coronaviridae Infections pip...

April 2021 35 pages

Corrosive Esophagitis (Erosive Esophagitis) (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Corrosive Esophagitis (Erosive Esophagitis) (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Corrosive Esophagitis (Erosive Esophagitis) (Gastrointestinal) - Drugs in Development, 2021 provides...

April 2021 30 pages

Corticobasal Degeneration (CBD/CBGD/Cortical Basal Ganglionic Degeneration) (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Corticobasal Degeneration (CBD/CBGD/Cortical Basal Ganglionic Degeneration) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Corticobasal Degeneration (CBD/CBGD/Cortical Basal Ganglionic...

April 2021 30 pages

Corticotropin Releasing Factor Receptor 1 (Corticotropin Releasing Hormone Receptor 1 or CRHR1) - Drugs in Development, 2021

US$ 3,000.00

Corticotropin Releasing Factor Receptor 1 (Corticotropin Releasing Hormone Receptor 1 or CRHR1) - Drugs in Development, 2021 SUMMARY Corticotropin Releasing Factor Receptor 1 (Corticotropin Releasing...

April 2021 35 pages

CREB Binding Protein (CREBBP or EC 2.3.1.48) - Drugs in Development, 2021

US$ 3,000.00

CREB Binding Protein (CREBBP or EC 2.3.1.48) - Drugs in Development, 2021 SUMMARY CREB Binding Protein (CREBBP or EC 2.3.1.48) - Drugs in Development, 2021 provides in depth analysis on CREB Binding P...

April 2021 40 pages

Creutzfeldt Jakob Disease (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Creutzfeldt Jakob Disease (Central Nervous System) - Drugs in Development, 2021 SUMMARY Creutzfeldt Jakob Disease (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Creu...

April 2021 35 pages

Crimean-Congo Hemorrhagic Fever (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Crimean-Congo Hemorrhagic Fever (Infectious Disease) - Drugs in Development, 2021 SUMMARY Crimean-Congo Hemorrhagic Fever (Infectious Disease) - Drugs in Development, 2021 provides an overview of the...

April 2021 35 pages

Cruzipain (Major Cysteine Proteinase or Cruzain or EC 3.4.22.51) - Drugs in Development, 2021

US$ 3,000.00

Cruzipain (Major Cysteine Proteinase or Cruzain or EC 3.4.22.51) - Drugs in Development, 2021 SUMMARY Cruzipain (Major Cysteine Proteinase or Cruzain or EC 3.4.22.51) - Drugs in Development, 2021 prov...

April 2021 30 pages

Cryptococcal Meningitis (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Cryptococcal Meningitis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Cryptococcal Meningitis (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Cryptococcal Men...

April 2021 35 pages

Cushing's Syndrome (Metabolic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Cushing's Syndrome (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Cushing's Syndrome (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of the Cushing's Syndrome pipel...

April 2021 40 pages

Cutaneous Lupus Erythematosus (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Cutaneous Lupus Erythematosus (Immunology) - Drugs in Development, 2021 SUMMARY Cutaneous Lupus Erythematosus (Immunology) - Drugs in Development, 2021 provides an overview of the Cutaneous Lupus Eryt...

April 2021 35 pages

Cutaneous T-Cell Lymphoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Cutaneous T-Cell Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY Cutaneous T-Cell Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the Cutaneous T-Cell Lymphoma pipeli...

April 2021 105 pages

Cyclic GMP-AMP Synthase (2'3'-cGAMP Synthase or Mab 21 Domain Containing Protein 1 or CGAS or EC 2.7.7.86) - Drugs in Development, 2021

US$ 3,000.00

Cyclic GMP-AMP Synthase (2'3'-cGAMP Synthase or Mab 21 Domain Containing Protein 1 or CGAS or EC 2.7.7.86) - Drugs in Development, 2021 SUMMARY Cyclic GMP-AMP Synthase (2'3'-cGAMP Synthase or Mab 21 D...

April 2021 30 pages

Cyclin Dependent Kinase (CDK or EC 2.7.11.22) - Drugs in Development, 2021

US$ 3,000.00

Cyclin Dependent Kinase (CDK or EC 2.7.11.22) - Drugs in Development, 2021 SUMMARY Cyclin Dependent Kinase (CDK or EC 2.7.11.22) - Drugs in Development, 2021 provides in depth analysis on Cyclin Depen...

April 2021 35 pages

Cyclin Dependent Like Kinase 5 (Serine/Threonine Protein Kinase PSSALRE or Tau Protein Kinase II Catalytic Subunit or Cell Division Protein Kinase 5 or CDK5 or EC 2.7.11.1) - Drugs in Development, 2021

US$ 3,000.00

Cyclin Dependent Like Kinase 5 (Serine/Threonine Protein Kinase PSSALRE or Tau Protein Kinase II Catalytic Subunit or Cell Division Protein Kinase 5 or CDK5 or EC 2.7.11.1) - Drugs in Development, 202...

April 2021 30 pages

Cystine/Glutamate Transporter (Amino Acid Transport System Xc or Calcium Channel Blocker Resistance Protein CCBR1 or Solute Carrier Family 7 Member 11 or xCT or SLC7A11) - Drugs in Development, 2021

US$ 3,000.00

Cystine/Glutamate Transporter (Amino Acid Transport System Xc or Calcium Channel Blocker Resistance Protein CCBR1 or Solute Carrier Family 7 Member 11 or xCT or SLC7A11) - Drugs in Development, 2021 S...

April 2021 30 pages

Cystinuria (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Cystinuria (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Cystinuria (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Cystinuria pipeline landscape. The report pr...

April 2021 30 pages

Cytokine Receptor Common Subunit Gamma (Interleukin 2 Receptor Subunit Gamma or GammaC or p64 or CD132 or IL2RG) - Drugs in Development, 2021

US$ 3,000.00

Cytokine Receptor Common Subunit Gamma (Interleukin 2 Receptor Subunit Gamma or GammaC or p64 or CD132 or IL2RG) - Drugs in Development, 2021 SUMMARY Cytokine Receptor Common Subunit Gamma (Interleuki...

April 2021 50 pages

Cytokine Release Syndrome (Cytokine Storm) (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Cytokine Release Syndrome (Cytokine Storm) (Immunology) - Drugs in Development, 2021 SUMMARY Cytokine Release Syndrome (Cytokine Storm) (Immunology) - Drugs in Development, 2021 provides an overview o...

April 2021 65 pages

Cytopenia (Hematological Disorders) - Drugs in Development, 2021

US$ 2,000.00

Cytopenia (Hematological Disorders) - Drugs in Development, 2021 SUMMARY Cytopenia (Hematological Disorders) - Drugs in Development, 2021 provides an overview of the Cytopenia pipeline landscape. The...

April 2021 30 pages

Cytosolic Phospholipase A2 (Phospholipase A2 Group IVA or PLA2G4A or EC 3.1.1.4 or EC 3.1.1.5) - Drugs in Development, 2021

US$ 3,000.00

Cytosolic Phospholipase A2 (Phospholipase A2 Group IVA or PLA2G4A or EC 3.1.1.4 or EC 3.1.1.5) - Drugs in Development, 2021 SUMMARY Cytosolic Phospholipase A2 (Phospholipase A2 Group IVA or PLA2G4A or...

April 2021 35 pages

Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Drugs in Development, 2021

US$ 3,000.00

Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Drugs in Development, 2021 SUMMARY Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associate...

April 2021 140 pages

D Amino Acid Oxidase (DAAO or DAMOX or DAO or EC 1.4.3.3) - Drugs in Development, 2021

US$ 3,000.00

D Amino Acid Oxidase (DAAO or DAMOX or DAO or EC 1.4.3.3) - Drugs in Development, 2021 SUMMARY D Amino Acid Oxidase (DAAO or DAMOX or DAO or EC 1.4.3.3) - Drugs in Development, 2021 provides in depth...

April 2021 30 pages

D1A Dopamine Receptor (Dopamine D1 Receptor or DRD1) - Drugs in Development, 2021

US$ 3,000.00

D1A Dopamine Receptor (Dopamine D1 Receptor or DRD1) - Drugs in Development, 2021 SUMMARY D1A Dopamine Receptor (Dopamine D1 Receptor or DRD1) - Drugs in Development, 2021 provides in depth analysis o...

April 2021 70 pages

D1B Dopamine Receptor (D5 Dopamine Receptor or D1 Beta Dopamine Receptor or Dopamine D5 Receptor or DRD5) - Drugs in Development, 2021

US$ 3,000.00

D1B Dopamine Receptor (D5 Dopamine Receptor or D1 Beta Dopamine Receptor or Dopamine D5 Receptor or DRD5) - Drugs in Development, 2021 SUMMARY D1B Dopamine Receptor (D5 Dopamine Receptor or D1 Beta Do...

April 2021 45 pages

D2 Dopamine Receptor (Dopamine D2 Receptor or DRD2) - Drugs in Development, 2021

US$ 3,500.00

D2 Dopamine Receptor (Dopamine D2 Receptor or DRD2) - Drugs in Development, 2021 SUMMARY D2 Dopamine Receptor (Dopamine D2 Receptor or DRD2) - Drugs in Development, 2021 provides in depth analysis on...

April 2021 190 pages

D3 Dopamine Receptor (Dopamine D3 Receptor or DRD3) - Drugs in Development, 2021

US$ 3,000.00

D3 Dopamine Receptor (Dopamine D3 Receptor or DRD3) - Drugs in Development, 2021 SUMMARY D3 Dopamine Receptor (Dopamine D3 Receptor or DRD3) - Drugs in Development, 2021 provides in depth analysis on...

April 2021 95 pages

D4 Dopamine Receptor (D2C Dopamine Receptor or Dopamine D4 Receptor or DRD4) - Drugs in Development, 2021

US$ 3,000.00

D4 Dopamine Receptor (D2C Dopamine Receptor or Dopamine D4 Receptor or DRD4) - Drugs in Development, 2021 SUMMARY D4 Dopamine Receptor (D2C Dopamine Receptor or Dopamine D4 Receptor or DRD4) - Drugs i...

April 2021 50 pages

Dedifferentiated Liposarcoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Dedifferentiated Liposarcoma (Oncology) - Drugs in Development, 2021 SUMMARY Dedifferentiated Liposarcoma (Oncology) - Drugs in Development, 2021 provides an overview of the Dedifferentiated Liposarco...

April 2021 45 pages

Delayed Graft Function (DGF) (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Delayed Graft Function (DGF) (Immunology) - Drugs in Development, 2021 SUMMARY Delayed Graft Function (DGF) (Immunology) - Drugs in Development, 2021 provides an overview of the Delayed Graft Function...

April 2021 35 pages

Delirium (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Delirium (Central Nervous System) - Drugs in Development, 2021 SUMMARY Delirium (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Delirium pipeline landscape. The repor...

April 2021 30 pages

Delta Type Opioid Receptor (DOR1 or OPRD or OPRD1) - Drugs in Development, 2021

US$ 3,000.00

Delta Type Opioid Receptor (DOR1 or OPRD or OPRD1) - Drugs in Development, 2021 SUMMARY Delta Type Opioid Receptor (DOR1 or OPRD or OPRD1) - Drugs in Development, 2021 provides in depth analysis on De...

April 2021 105 pages

Dementia Associated With Alzheimer's Disease (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Dementia Associated With Alzheimer's Disease (Central Nervous System) - Drugs in Development, 2021 SUMMARY Dementia Associated With Alzheimer's Disease (Central Nervous System) - Drugs in Development,...

April 2021 65 pages

Demyelinating Diseases (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Demyelinating Diseases (Central Nervous System) - Drugs in Development, 2021 SUMMARY Demyelinating Diseases (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Demyelinat...

April 2021 40 pages

Filters

Clear all